(R)-3-methoxy-N-((R)-1-((S)-3-(4-methoxyphenyl)-1-((S)-1-((R)-2-methyloxiran-2-yl)-1-oxo-3-phenylpropan-2-ylamino)-1-oxopropan-2-ylamino)-1-oxopropan-2-yl)piperidine-1-carboxamide

ID: ALA4877708

Chembl Id: CHEMBL4877708

PubChem CID: 164628036

Max Phase: Preclinical

Molecular Formula: C32H42N4O7

Molecular Weight: 594.71

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(C[C@H](NC(=O)[C@@H](C)NC(=O)N2CCC[C@@H](OC)C2)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]2(C)CO2)cc1

Standard InChI:  InChI=1S/C32H42N4O7/c1-21(33-31(40)36-16-8-11-25(19-36)42-4)29(38)35-27(18-23-12-14-24(41-3)15-13-23)30(39)34-26(28(37)32(2)20-43-32)17-22-9-6-5-7-10-22/h5-7,9-10,12-15,21,25-27H,8,11,16-20H2,1-4H3,(H,33,40)(H,34,39)(H,35,38)/t21-,25-,26+,27+,32-/m1/s1

Standard InChI Key:  YILOYOGEUIDELY-WBKCPQTRSA-N

Alternative Forms

  1. Parent:

    ALA4877708

    ---

Associated Targets(Human)

PSMB8 Tclin Proteasome subunit beta type-8 (743 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PSMB5 Tclin Proteasome Macropain subunit MB1 (2451 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PSMA1 Tclin Proteasome subunit alpha type-1 (6 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PSMB9 Tchem Proteasome subunit beta type-9 (308 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PSMB4 Tbio Proteasome subunit beta type-4 (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PSMB10 Tchem Proteasome subunit beta type-10 (258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPMI-8226 (44974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MM1.S (1111 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 594.71Molecular Weight (Monoisotopic): 594.3053AlogP: 2.02#Rotatable Bonds: 13
Polar Surface Area: 138.60Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.11CX Basic pKa: CX LogP: 2.48CX LogD: 2.48
Aromatic Rings: 2Heavy Atoms: 43QED Weighted: 0.30Np Likeness Score: -0.18

References

1. Li X, Hong D, Zhang M, Xu L, Zhou Y, Li J, Liu T..  (2021)  Development of peptide epoxyketones as selective immunoproteasome inhibitors.,  221  [PMID:34087498] [10.1016/j.ejmech.2021.113556]

Source